Custom service

Peptide Radioisotope Conjugation (PRC)

Prepare radioisotope-labeled peptide precursors and cold standards for nuclear-medicine research

Turnaround: 4–8 weeksTypical scale: 0.1–50 mg conjugate per batchChemistry options: I-125/I-131 iodination chemistry; chelator-based radiometal labeling routes; cold-reference standard synthesis

Peptide Radioisotope Conjugation (PRC) supports programmes that prepare radioisotope-labeled peptide precursors and cold standards for nuclear-medicine research. In a typical engagement we plan the I-125/I-131 iodination chemistry route first, confirm compatibility with chelator-based radiometal labeling routes, and release precursor and cold standard with radiochemical QC protocol on a 4–8 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep I-125/I-131 iodination chemistry as the primary option and hold chelator-based radiometal labeling routes in reserve, so that scale-up never depends on an unproven step.

Preclinical radiotracer development

Cold standards for clinical radiopharmacies

Isotope work that requires a licensed radioactive facility on our side

Conjugates whose payload cannot tolerate aqueous coupling conditions

Every conjugation batch is documented from vial to vial: carrier lot, payload lot, reagent lots, reaction conditions and purification chromatograms. The release package contains the loading ratio measured by an orthogonal method (UV, ICP-MS or amino-acid analysis), identity by mass spectrometry where the conjugate permits it, and residual-free-payload data.

Service Highlights

  • I-125/I-131 iodination chemistry as the default route, with chelator-based radiometal labeling routes held as a proven fallback
  • Cold-reference standard synthesis worked into the design where the application requires it
  • Carrier and payload compatibility screened in a small feasibility batch before full material is committed
  • Analytical confirmation of every intermediate before the final release
  • Unreacted payload driven below the detection limit of the release assay before purification is closed
  • Precursor and cold standard with radiochemical QC protocol delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Scope & design

    We review the payload, the carrier and the intended assay or study, and propose between I-125/I-131 iodination chemistry and chelator-based radiometal labeling routes as candidate routes.

  2. Feasibility screen

    A milligram-scale screen compares loading, residual payload and activity across the candidate conditions.

  3. Production conjugation

    The selected condition is executed at project scale with in-process sampling at fixed time points.

  4. Purification

    Size-exclusion, dialysis or magnetic separation removes free payload and by-products.

  5. Characterization & release

    Identity, loading ratio and functional activity are measured against the agreed specification.

  6. Documentation & hand-off

    Precursor and cold standard with radiochemical QC protocol is packaged with the full batch record, released for shipment after QC sign-off.

Specifications & timeline

Turnaround
4–8 weeks
Typical scale
0.1–50 mg conjugate per batch
Chemistry options
I-125/I-131 iodination chemistry; chelator-based radiometal labeling routes; cold-reference standard synthesis
Deliverable
Precursor and cold standard with radiochemical QC protocol
QC package
HPLC/SEC trace, MALDI-TOF or ESI-MS, UV/Vis or ICP-MS loading ratio
Shipping
Blue ice or dry ice as the payload requires, with a cold-chain manifest

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.